Protein O-glycosylation is a critical modification in the brain, as genetic variants in the pathway are associated with both common and severe neuropsychiatric phenotypes. However, little is known about the most abundant type of O-glycan in the mammalian brain, which are O-GalNAc linked. Here, we determined the spatial localization, protein carriers, and cellular function of O-GalNAc glycans in mouse brain. We observed striking spatial enrichment of O-GalNAc glycans in white matter tracts and at nodes of Ranvier. Glycoproteomic analysis revealed that more than half of the identified O-GalNAc glycans were present on chondroitin sulfate proteoglycans termed lecticans, and display both domain enrichment and site-specific heterogeneity. Though genetic ablation in a single cell type failed to replicate the severe phenotypes seen in congenital disorders, inhibition of O-GalNAc synthesis in neurons reduced binding of Siglec-4, a known regulator neurite growth, and shortened the length of nodes of Ranvier. This work highlights a new function of O-GalNAc glycans in the brain and will inform future studies on their role in development and disease.
No takes yet. Share an insight, caveat, or question.
Noël et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: